[go: up one dir, main page]

WO2018226191A3 - Use of a herbal formulation containing linseed oil in the treatment of mild gastrointestinal (gastrointestinal system) disorders - Google Patents

Use of a herbal formulation containing linseed oil in the treatment of mild gastrointestinal (gastrointestinal system) disorders Download PDF

Info

Publication number
WO2018226191A3
WO2018226191A3 PCT/TR2018/050102 TR2018050102W WO2018226191A3 WO 2018226191 A3 WO2018226191 A3 WO 2018226191A3 TR 2018050102 W TR2018050102 W TR 2018050102W WO 2018226191 A3 WO2018226191 A3 WO 2018226191A3
Authority
WO
WIPO (PCT)
Prior art keywords
gastrointestinal
linseed oil
disorders
treatment
formulation containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2018/050102
Other languages
French (fr)
Other versions
WO2018226191A9 (en
WO2018226191A2 (en
Inventor
Mevlüt Büyükhelvacigi̇l
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Original Assignee
Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS filed Critical Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Publication of WO2018226191A2 publication Critical patent/WO2018226191A2/en
Publication of WO2018226191A3 publication Critical patent/WO2018226191A3/en
Publication of WO2018226191A9 publication Critical patent/WO2018226191A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

In pharmaceutical industry; the invention relates to use of an herbal formulation containing linseed oil being rich in alpha-linolenic acid (ALA) that is a herbal Omega 3 fatty acid in the treatment of gastrointestinal (related to gastrointestinal system) disorders. Said herbal formulation comprises linseed oil, dl α-tocopherol, dl α-tocopheril acetate, glycerin, purified water and gelatin maintaining the integrity and formation of the content.
PCT/TR2018/050102 2017-03-23 2018-03-16 Use of a herbal formulation containing linseed oil in the treatment of mild gastrointestinal (gastrointestinal system) disorders Ceased WO2018226191A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/04364 2017-03-23
TR2017/04364A TR201704364A2 (en) 2017-03-23 2017-03-23 THE USE OF A HERBAL FORMULATION CONTAINING LINEN SEED OIL IN THE TREATMENT OF LIGHT GASTROINTESTINAL DISEASES

Publications (3)

Publication Number Publication Date
WO2018226191A2 WO2018226191A2 (en) 2018-12-13
WO2018226191A3 true WO2018226191A3 (en) 2019-02-21
WO2018226191A9 WO2018226191A9 (en) 2019-04-11

Family

ID=64567372

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050102 Ceased WO2018226191A2 (en) 2017-03-23 2018-03-16 Use of a herbal formulation containing linseed oil in the treatment of mild gastrointestinal (gastrointestinal system) disorders

Country Status (2)

Country Link
TR (1) TR201704364A2 (en)
WO (1) WO2018226191A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033636A1 (en) * 1998-12-08 2000-06-15 Rick Heintzman Stabilization of ground plant seeds
EP2070545A1 (en) * 2007-12-11 2009-06-17 Bios Line S.p.a. Oral compositions for the prevention and treatment of inflammatory disorders of the colon
CN105266036A (en) * 2015-11-17 2016-01-27 黑龙江省科学院微生物研究所 Preparation method of natto soft capsule health-care food having intestinal conditioning and immunity adjusting functions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033636A1 (en) * 1998-12-08 2000-06-15 Rick Heintzman Stabilization of ground plant seeds
EP2070545A1 (en) * 2007-12-11 2009-06-17 Bios Line S.p.a. Oral compositions for the prevention and treatment of inflammatory disorders of the colon
CN105266036A (en) * 2015-11-17 2016-01-27 黑龙江省科学院微生物研究所 Preparation method of natto soft capsule health-care food having intestinal conditioning and immunity adjusting functions

Also Published As

Publication number Publication date
WO2018226191A9 (en) 2019-04-11
WO2018226191A2 (en) 2018-12-13
TR201704364A2 (en) 2017-07-21

Similar Documents

Publication Publication Date Title
WO2013170006A3 (en) Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
MX390089B (en) COMPOSITIONS OF REFINED OIL AND METHODS FOR ITS PREPARATION.
EA201791537A1 (en) PHARMACEUTICAL COMPOSITION ON THE BASIS OF NANOPARTICLES OF DOCETAXEL-ALBUMIN, METHOD FOR ITS PREPARATION AND ITS APPLICATION
MY181997A (en) Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid
MX2017016320A (en) Nutritional compositions and methods for promoting cognitive development.
MX2018000143A (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid.
GEP20237543B (en) Pharmaceutical composition comprising omega fatty acids, and infusion preparation comprising the same
WO2017037075A8 (en) Composition containing echinacea extract and linoleic acid derivatives
MY199653A (en) Encapsulated nutritional and pharmaceutical compositions
WO2016191744A8 (en) Oral composition of celecoxib for treatment of pain
PH12017500269A1 (en) Composite formulation for oral administration comprising omega-3 fatty acid esters and statins
MX2021009825A (en) NUTRITIONAL SUPPLEMENT.
EP4450090A3 (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
WO2017062523A3 (en) Oil compositions and methods of making
SG11201804550SA (en) Method for enriching protists with lipids rich in polyunsaturated fatty acids, more particularly of the omega 3 class, and implementation of same for the production of said lipids
WO2016005962A3 (en) Stable liquid formulations of cyclophosphamide and processes
WO2018226191A3 (en) Use of a herbal formulation containing linseed oil in the treatment of mild gastrointestinal (gastrointestinal system) disorders
MY186566A (en) Omega-3 compositions, dosage forms, and methods of use
EA201790622A1 (en) THERAPEUTIC AND NUTRITIONAL COMPOSITIONS FOR FUNCTIONAL WORKING DISABILITIES OF THE DIGESTIVE SYSTEM
WO2018222167A3 (en) Use of a herbal formulation containing linseed oil in the treatment of cardiovascular system diseases
WO2018226192A3 (en) Use of a herbal formulation containing linseed oil on those who cannot use fish oil, particularly on vegetarians as a herbal omega 3 (ala) source
WO2018222166A3 (en) Use of an herbal formulation containing linseed oil in the treatment of regulating some blood lipid (fat) levels
WO2015166419A3 (en) Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain
WO2019004968A3 (en) Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function
EA201992844A1 (en) NEW ORAL COMPOSITIONS BASED ON BELINOSTAT

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18813935

Country of ref document: EP

Kind code of ref document: A2